These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
89 related articles for article (PubMed ID: 8708548)
1. IGF-I potentiates interleukin-2 production in human peripheral T cells. Kooijman R; Rijkers GT; Zegers BJ J Endocrinol; 1996 May; 149(2):351-6. PubMed ID: 8708548 [TBL] [Abstract][Full Text] [Related]
2. Insulin-like growth factor-1 increases the mitogenic response of human peripheral blood lymphocytes to phytohemagglutinin. Roldan A; Charreau E; Schillaci R; Eugui EM; Allison AC Immunol Lett; 1989 Jan; 20(1):5-8. PubMed ID: 2541077 [TBL] [Abstract][Full Text] [Related]
3. Promotion of human T lymphocyte proliferation by IL-4. Mitchell LC; Davis LS; Lipsky PE J Immunol; 1989 Mar; 142(5):1548-57. PubMed ID: 2783946 [TBL] [Abstract][Full Text] [Related]
4. Effects of insulin-like growth factors and growth hormone on the in vitro proliferation of T lymphocytes. Kooijman R; Willems M; Rijkers GT; Brinkman A; van Buul-Offers SC; Heijnen CJ; Zegers BJ J Neuroimmunol; 1992 May; 38(1-2):95-104. PubMed ID: 1374427 [TBL] [Abstract][Full Text] [Related]
5. Co-operative effect between insulin-like growth factor-1 and interleukin-2 on DNA synthesis and interleukin-2 receptor-alpha chain expression in human lymphocytes. Schillaci R; Brocardo MG; Roldán A Immunol Cell Biol; 1995 Aug; 73(4):340-5. PubMed ID: 7493771 [TBL] [Abstract][Full Text] [Related]
6. A cytokine, lymphocyte blastogenesis inhibitory factor (LBIF), arrests mitogen-stimulated T lymphocytes at early G1 phase with no influence on interleukin 2 production and interleukin 2 receptor light chain expression. Sugimura K; Ueda Y; Takeda K; Fukuda S; Tsukahara K; Habu Y; Fujiwara H; Azuma I Eur J Immunol; 1989 Aug; 19(8):1357-64. PubMed ID: 2673797 [TBL] [Abstract][Full Text] [Related]
7. Anti-CD26 monoclonal antibodies can reversibly arrest human T lymphocytes in the late G1 phase of the cell cycle. Mattern T; Ansorge S; Flad HD; Ulmer AJ Immunobiology; 1993 Jun; 188(1-2):36-50. PubMed ID: 8104880 [TBL] [Abstract][Full Text] [Related]
8. Stimulatory roles of muscarinic acetylcholine receptors on T cell antigen receptor/CD3 complex-mediated interleukin-2 production in human peripheral blood lymphocytes. Fujino H; Kitamura Y; Yada T; Uehara T; Nomura Y Mol Pharmacol; 1997 Jun; 51(6):1007-14. PubMed ID: 9187267 [TBL] [Abstract][Full Text] [Related]
9. T cell triggering by lectins. I. Requirements for interleukin 2 production; lectin concentration determines the accessory cell dependency. Roosnek EE; Brouwer MC; Aarden LA Eur J Immunol; 1985 Jul; 15(7):652-6. PubMed ID: 3874077 [TBL] [Abstract][Full Text] [Related]
10. Quantitative and qualitative signals determine T-cell cycle entry and progression. Modiano JF; Mayor J; Ball C; Chitko-McKown CG; Sakata N; Domenico-Hahn J; Lucas JJ; Gelfand EW Cell Immunol; 1999 Oct; 197(1):19-29. PubMed ID: 10555992 [TBL] [Abstract][Full Text] [Related]
11. T-cells infiltrating renal cell carcinoma display a poor proliferative response even though they can produce interleukin 2 and express interleukin 2 receptors. Alexander JP; Kudoh S; Melsop KA; Hamilton TA; Edinger MG; Tubbs RR; Sica D; Tuason L; Klein E; Bukowski RM Cancer Res; 1993 Mar; 53(6):1380-7. PubMed ID: 8443817 [TBL] [Abstract][Full Text] [Related]
12. Comparative effects of tumor necrosis factor-alpha and IL-1 beta on mitogen-induced T cell activation. Hackett RJ; Davis LS; Lipsky PE J Immunol; 1988 Apr; 140(8):2639-44. PubMed ID: 2965728 [TBL] [Abstract][Full Text] [Related]
13. Apolipoprotein E inhibition of proliferation of mitogen-activated T lymphocytes: production of interleukin 2 with reduced biological activity. Kelly ME; Clay MA; Mistry MJ; Hsieh-Li HM; Harmony JA Cell Immunol; 1994 Dec; 159(2):124-39. PubMed ID: 7994749 [TBL] [Abstract][Full Text] [Related]
14. Morphine-induced suppression of thymocyte proliferation is mediated by inhibition of IL-2 synthesis. Roy S; Loh HH; Barke RA Adv Exp Med Biol; 1995; 373():41-8. PubMed ID: 7668159 [No Abstract] [Full Text] [Related]
15. Role of insulin-like growth factor-1 on the kinetics of human lymphocytes stimulation in serum-free culture medium. Schillaci R; Ribaudo CM; Rondinone CM; Roldán A Immunol Cell Biol; 1994 Aug; 72(4):300-5. PubMed ID: 7806263 [TBL] [Abstract][Full Text] [Related]
16. Interleukin 2 and mitogen driven proliferation in human peripheral mononuclear cells: a kinetic analysis. Ferrero E; Manfredi A; Bianchi E; Schönheit A; Sabbadini MG; Rugarli C Haematologica; 1989; 74(4):355-8. PubMed ID: 2507408 [TBL] [Abstract][Full Text] [Related]
17. Expression and function of insulin-like growth factor receptors on anti-CD3-activated human T lymphocytes. Johnson EW; Jones LA; Kozak RW J Immunol; 1992 Jan; 148(1):63-71. PubMed ID: 1345791 [TBL] [Abstract][Full Text] [Related]
18. Anti-CD28 antibody- and IL-4-induced human T cell proliferation is sensitive to rapamycin. Luo H; Chen H; Daloze P; St-Louis G; Wu J Clin Exp Immunol; 1993 Nov; 94(2):371-6. PubMed ID: 8222329 [TBL] [Abstract][Full Text] [Related]
19. Insulin-like growth factor-I stimulates IL-10 production in human T cells. Kooijman R; Coppens A J Leukoc Biol; 2004 Oct; 76(4):862-7. PubMed ID: 15277570 [TBL] [Abstract][Full Text] [Related]
20. Functional and molecular aspects of transient T cell unresponsiveness: role of selective interleukin-2 deficiency. Köller MD; Kiener HP; Aringer M; Graninger WB; Meuer S; Samstag Y; Smolen JS Clin Exp Immunol; 2003 May; 132(2):225-31. PubMed ID: 12699409 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]